Skip to main content
. 2021 Mar 2;11(3):171. doi: 10.3390/jpm11030171

Table 1.

Demographic and clinical variables of the patients with idiopathic Bell’s palsy.

Variable All, n (%) Favorable Outcome, n (%) Unfavorable Outcome, n (%) p-Value
Patients, n 396 (100) 354 (89.4) 42 (10.6)
Age, years 0.354
<60 314 (79.3) 283 (79.9) 31 (73.8)
≥60 82 (20.7) 71 (20.1) 11 (26.2)
Sex 0.103
Female 179 (45.2) 165 (46.6) 14 (33.3)
Male 217 (54.8) 189 (53.4) 28 (66.7)
Affected site 0.279
Right 195 (50.8) 183 (51.7) 18 (42.9)
Left 201 (49.2) 171 (48.3) 24 (57.1)
Smoking 0.208
No 329 (83.1) 297 (83.9) 32 (76.2)
Yes 67 (16.9) 57 (16.1) 10 (23.8)
Alcohol drinking 0.226
No 352 (88.9) 317 (89.5) 35 (83.3)
Yes 44 (11.1) 37 (10.5) 7 (16.7)
Betel nut chewing 0.074
No 373 (94) 336 (94.9) 37 (88.1)
Yes 23 (6) 18 (5.1) 5 (11.9)
Diabetes 0.364
No 339 (85.6) 305 (86.2) 34 (81)
Yes 57 (14.4) 49 (13.8) 8 (19)
Hypertension 0.849
No 334 (84.3) 299 (84.5) 35 (83.3)
Yes 62 (15.7) 55 (15.5) 7 (16.7)
Hyperlipidemia 0.489
No 384 (97) 344 (97.2) 40 (95.2)
Yes 12 (3) 10 (28.2) 2 (4.8)
Blink reflex 0.0001 *
Delayed 149 (37.6) 145 (41) 4 (9.5)
Absent 247 (62.4) 209 (59) 38 (90.5)
Electroneurography <0.0001 *
>33% 254 (64.1) 244 (68.9) 10 (23.8)
≤33% 142 (35.9) 110 (31.1) 32 (76.2)
Treatment 0.719
Supportive care 14 (3.5) 12 (3.4) 2 (4.8)
Low-dose steroid a 249 (62.9) 221 (62.4) 28 (66.7)
High-dose steroid b 133 (33.6) 121 (34.2) 12 (28.6)

a Low-dose steroid was defined as ≤0.5 mg/kg prednisolone/day. b High-dose steroid was defined as >0.5 mg/kg prednisolone/day. *: p < 0.05.